» Articles » PMID: 10611229

Role of the Distal Half of the C-Mpl Intracellular Domain in Control of Platelet Production by Thrombopoietin in Vivo

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 Dec 28
PMID 10611229
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The cytokine thrombopoietin (TPO) controls the formation of megakaryocytes and platelets from hematopoietic stem cells. TPO exerts its effect through activation of the c-Mpl receptor and of multiple downstream signal transduction pathways. While the membrane-proximal half of the cytoplasmic domain appears to be required for the activation of signaling molecules that drive proliferation, the distal half and activation of the mitogen-activated protein kinase pathway have been implicated in mediating megakaryocyte maturation in vitro. To investigate the contribution of these two regions of c-Mpl and the signaling pathways they direct in mediating the function of TPO in vivo, we used a knock-in (KI) approach to delete the carboxy-terminal 60 amino acids of the c-Mpl receptor intracellular domain. Mice lacking the C-terminal 60 amino acids of c-Mpl (Delta60 mice) have normal platelet and megakaryocyte counts compared to wild-type mice. Furthermore, platelets in the KI mice are functionally normal, indicating that activation of signaling pathways connected to the C-terminal half of the receptor is not required for megakaryocyte differentiation or platelet production. However, Delta60 mice have an impaired response to exogenous TPO stimulation and display slower recovery from myelosuppressive treatment, suggesting that combinatorial signaling by both ends of the receptor intracellular domain is necessary for an appropriate acute response to TPO.

Citing Articles

Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease.

Behrens K, Kauppi M, Viney E, Kueh A, Hyland C, Willson T Leukemia. 2024; 38(6):1342-1352.

PMID: 38491305 PMC: 11147766. DOI: 10.1038/s41375-024-02219-5.


Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development.

Balligand T, Achouri Y, Pecquet C, Gaudray G, Colau D, Hug E Leukemia. 2019; 34(2):510-521.

PMID: 31471561 DOI: 10.1038/s41375-019-0538-1.


Role of tumor suppressor p53 in megakaryopoiesis and platelet function.

Apostolidis P, Woulfe D, Chavez M, Miller W, Papoutsakis E Exp Hematol. 2011; 40(2):131-42.e4.

PMID: 22024107 PMC: 3258354. DOI: 10.1016/j.exphem.2011.10.006.


Thrombopoietin and hematopoietic stem cells.

de Graaf C, Metcalf D Cell Cycle. 2011; 10(10):1582-9.

PMID: 21478671 PMC: 3127159. DOI: 10.4161/cc.10.10.15619.


Megakaryopoiesis.

Geddis A Semin Hematol. 2010; 47(3):212-9.

PMID: 20620431 PMC: 2904992. DOI: 10.1053/j.seminhematol.2010.03.001.


References
1.
Gurney A, Wong S, Henzel W, de Sauvage F . Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci U S A. 1995; 92(12):5292-6. PMC: 41680. DOI: 10.1073/pnas.92.12.5292. View

2.
Lieschke G, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C . Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84(6):1737-46. View

3.
Levin J, Peng J, Baker G, Villeval J, Lecine P, BURSTEIN S . Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2. Blood. 1999; 94(9):3037-47. View

4.
Sattler M, Durstin M, Frank D, Okuda K, Kaushansky K, Salgia R . The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Exp Hematol. 1995; 23(9):1040-8. View

5.
Fielder P, Gurney A, Stefanich E, Marian M, Moore M, de Sauvage F . Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 1996; 87(6):2154-61. View